Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.45 |
| ▸ | ADH1A | P07327 | 3/20 | 0.41 |
| ▸ | ADH1C | P00326 | 2/20 | 0.41 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | PHGDH | O43175 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27903716 | 1.00 | HRH3 (0.45) | HRH3HRH4ADH1AADH1CABCB11 | |
| SCHEMBL4351532 | 1.00 | HRH3 (0.45) | HRH3HRH4ADH1AADH1CABCB11 | |
| SCHEMBL20055097 | 0.95 | — | — | |
| SCHEMBL1847965 | 0.86 | — | — | |
| SCHEMBL3186493 | 0.80 | HRH3 (0.42) | HRH3HRH4ADH1AADH1CABCB11 | |
| Hydrochloric Acid SCHEMBL27567168 | 0.78 | HRH4 (0.41) | HRH3HRH4ADH1AADH1CABCB11 | |
| Hydrochloric Acid SCHEMBL6897821 | 0.78 | HRH4 (0.41) | HRH3HRH4ADH1AADH1CABCB11 | |
| SCHEMBL7691331 | 0.78 | HRH3 (0.48) | HRH3HRH4ADH1AADH1CABCB11 | |
| SCHEMBL24951938 | 0.77 | HRH4 (0.39) | HRH3HRH4ADH1AADH1CABCB11 | |
| SCHEMBL7857024 | 0.77 | PIK3CD (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347552-B1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2025-05-21 | — | — | EP | claimed |
| US-20240279155-A1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2024-08-22 | — | — | US | claimed |
| EP-4347552-A1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2024-04-10 | — | — | EP | claimed |
| CN-117425640-A | Method for producing isophorone diamine | 巴斯夫欧洲公司 | 2024-01-19 | — | — | CN | claimed |
| WO-2022253610-A1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2022-12-08 | — | — | WO | claimed |
| EP-4347552-B1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025078248-A1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2025-04-17 | — | — | WO | disclosed |
| EP-4511411-A1 | POLYASPARTATE-BASED TWO-COMPONENT COATING COMPOSITIONS FOR PRODUCING COATINGS HAVING GOOD SELF-HEALING PROPERTIES COUPLED WITH LOW TACKINESS | Covestro Deutschland AG (DE) | 2025-02-26 | — | — | EP | disclosed |
| EP-4453107-A1 | MULTILAYER CONSTRUCTION ON METAL SUBSTRATES BASED ON POLYASPARATE COATINGS | Covestro Deutschland AG (DE) | 2024-10-30 | — | — | EP | disclosed |
| US-20240279155-A1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2024-08-22 | — | — | US | disclosed |
| EP-4388025-A1 | NEW TWO-COMPONENT COATING SYSTEMS CONTAINING POLYASPARTIC ACID ESTERS | Covestro Deutschland AG (DE) | 2024-06-26 | — | — | EP | disclosed |
| EP-4347552-A1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2024-04-10 | — | — | EP | disclosed |
| WO-2023020960-A1 | NEW TWO-COMPONENT COATING SYSTEMS CONTAINING POLYASPARTIC ACID ESTERS | COVESTRO DEUTSCHLAND AG (DE) | 2023-02-23 | — | — | WO | disclosed |
| WO-2022253610-A1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | BASF SE (DE) | 2022-12-08 | — | — | WO | disclosed |
| EP-3959251-A1 | LATENT REACTIVE ADHESIVE PREPARATIONS | Covestro Intellectual Property GmbH & Co. KG (DE) | 2022-03-02 | — | — | EP | disclosed |
| EP-3927757-A1 | NOVEL TWO-COMPONENT OUTER COATING CONTAINING POLYASPARTIC ACID ESTERS | Covestro Intellectual Property GmbH & Co. KG (DE) | 2021-12-29 | — | — | EP | disclosed |
| EP-3927758-A1 | NOVEL TWO-COMPONENT CLEAR COAT SYSTEMS CONTAINING POLYASPARTIC ACID ESTER | Covestro Intellectual Property GmbH & Co. KG (DE) | 2021-12-29 | — | — | EP | disclosed |
| EP-3684834-A1 | POLYASPARTIC ACID ESTER COMPOSITIONS WHICH CONTAIN POLYASPARTIC ACID ESTERS WITH PRIMARY AMINO GROUPS AND SMALL AMOUNTS OF FUMARIC ACID DIALKYL ESTERS | Covestro Deutschland AG (DE) | 2020-07-29 | — | — | EP | disclosed |
| WO-2019057626-A1 | POLYASPARTIC ACID ESTER COMPOSITIONS WHICH CONTAIN POLYASPARTIC ACID ESTERS WITH PRIMARY AMINO GROUPS AND SMALL AMOUNTS OF FUMARIC ACID DIALKYL ESTERS | COVESTRO DEUTSCHLAND AG (DE) | 2019-03-28 | — | — | WO | disclosed |
| CN-103081145-A | Light emitting diode assembly and thermal control blanket and methods relating thereto | DU PONT | 2013-05-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279155-A1 | METHOD FOR MANUFACTURE OF ISOPHORONEDIAMINE | ICMT, HPN, DOHH | HRH3 1122/4885HRH4 622/4885ADH1A 626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.